Nuclear-Targeting Lipid Pt<sup>IV</sup> Prodrug Amphiphile Cooperates with siRNA for Enhanced Cancer Immunochemotherapy by Amplifying Pt-DNA Adducts and Reducing Phosphatidylserine Exposure-Reference-Cited by-同舟云学术

Nuclear-Targeting Lipid Pt^IV Prodrug Amphiphile Cooperates with siRNA for Enhanced Cancer Immunochemotherapy by Amplifying Pt-DNA Adducts and Reducing Phosphatidylserine Exposure

Published:2023-12-27 Issue:1 Volume:146 Page:1185-1195
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Wei Dengshuai¹,Fan Junning¹,Yan Jianqin¹,Liu Chaolong¹^ORCID,Cao Jie¹,Xu Chun²^ORCID,Sun Yong¹^ORCID,Xiao Haihua³^ORCID

Affiliation:

1. Department of Pharmaceutics, School of Pharmacy and Department of Epidemiology and Health Statistics, School of Public Health, Qingdao University, Qingdao 266021, China

2. School of Dentistry, The University of Queensland, Brisbane 4006, Australia

3. Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Polymer Physics and Chemistry, Institute of Chemistry Chinese Academy of Sciences, Beijing 100190, China

Funder

Natural Science Foundation of Qingdao Municipality

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/jacs.3c12706

Reference48 articles.

1. The rediscovery of platinum-based cancer therapy